Download Docs
Export
Print

Design

50044535 | Trademark

Interested in this case?

To schedule a demo, contact us at sales@docketalarm.com. Track this case, and find millions of cases like it, let us show you how.
Filed Aug. 11, 2026
Serial No. 50044535
Examining Attorney null
Class Pharmaceutical and biological preparations; Pharmaceutical and biological preparations for use as a gene editing therapy; Pharmaceutical and biological preparations for treating and managing hereditary angioedema (HAE) and complications caused by hereditary angioedema (HAE); Pharmaceutical and biological preparations for use as a one-time treatment for hereditary angioedema (HAE) due to C1 esterase inhibitor deficiency (Type 1 or Type 2); Pharmaceutical and biological preparations for use as a gene editing therapy that inactivates the KLKB1 gene and lowers plasma prekallikrein levels; Pharmaceutical and biological preparations for use as a gene editing therapy for hereditary angioedema (HAE); Pharmaceutical and biological preparations, namely, gene editing preparations for treating and managing swelling attacks; Therapeutic agents in the nature of a CRISPR/Cas9 system for treating hereditary angioedema (HAE); Pharmaceutical and biological preparations for the treatment of hereditary angioedema; 005; 006; 018; 044; 046; 051; 052
Design
Case Type Trademark
Status New application awaiting assignment to an examining attorney. <a href="https://www.uspto.gov/dashboard/trademarks/application-timeline.html">See current trademark processing wait times </a> for more information.
Last Updated: 4 hours ago
Filing Date # Docket Text